Analgesic Network Proposed By WFPMM

2 January 1995

The establishment of an international "Analgesics Network" has been proposed by the World Federation of Proprietary Medicine Manufacturers. The purpose of the network would be to share country-specific information on scientific and regulatory developments on over-the-counter analgesics and, as appropriate, bring international expertise to bear on industry's local interests.

Sharing information should be useful to members, according to the US Nonprescription Drug Manufacturers Association, and could be coordinated for association members through the NDMA's Internal Analgesic Task Group. The NDMA says it is currently soliciting feedback on participation in and information of the network from its own Internal Analgesic/Antirheumatic Task Force, Scientific Affairs and International Affairs committees, and calls for interested parties to contact (at the NDMA) William Soller or David Spangler. Phone: +1 202 429 9260; fax: +1 202 223 6835.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight